Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain
Tolerance to the pain-relieving effects of cannabinoids limits the therapeutic potential of these drugs in patients with chronic pain. Recent preclinical research with rodents and clinical studies in humans has suggested important differences between males and females in the development of tolerance...
Main Authors: | Angela N. Henderson-Redmond, LaTaijah C. Crawford, Diana E. Sepulveda, David E. Hale, Julia J. Lesperance, Daniel J. Morgan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.684115/full |
Similar Items
-
Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01) -
Studies of the anticonvulsant spectrum of delta 9 - tetrahydrocannabinol in rats
by: Reinking, Jeffrey Carl
Published: (1976) -
Sodium channel activation mechanisms : insights from deuterium oxide and delta-9-tetrahydrocannabinol substitution
by: Alicata, Daniel Andrew
Published: (2009) -
Acute human exposure assessment to tetrahydrocannabinol (Δ9‐THC)
by: European Food Safety Authority (EFSA), et al.
Published: (2020-01-01) -
Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)